Australia
# |
Name |
Goodwill |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 8.08 B
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
2 |
USD 182.26 M
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
|
3 |
USD 134.45 M
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
4 |
USD 105.80 M
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
5 |
USD 3.30 M
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
6 |
USD 73.32 K
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
7 |
USD 0.00
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
8 |
USD 0.00
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
|
9 |
USD 0.00
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
10 |
USD 0.00
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
The Clinical Trials company in Australia with the highest Goodwill is CSL Limited (ASX: CSL.AX) at USD 8.08 B.
The Clinical Trials company in Australia with the lowest Goodwill is Anteris Technologies Ltd (ASX: AVR.AX) at USD 0.00.
The top 10 Clinical Trials companies in Australia by Goodwill are CSL Limited, Monash IVF Group Limited, Mesoblast Limited, Australian Clinical Labs Limited, Telix Pharmaceuticals Limited, Immutep Limited, Clinuvel Pharmaceuticals Limited, Cogstate Limited, PolyNovo Limited and Anteris Technologies Ltd.
The bottom 10 Clinical Trials companies in Australia by Goodwill are Anteris Technologies Ltd, PolyNovo Limited, Cogstate Limited, Clinuvel Pharmaceuticals Limited, Immutep Limited, Telix Pharmaceuticals Limited, Australian Clinical Labs Limited, Mesoblast Limited, Monash IVF Group Limited and CSL Limited.